Angiogenesis and blood vessel stability in inflammatory arthritis

Arthritis and Rheumatism

Volumn 62, Issue 3, 2010, Pages 711-721

  Kennedy, Aisling ^a   Ng, Chin Teck ^a   Biniecka, Monika ^a   Saber, Tajvur ^a   Taylor, Cormac ^a   O'Sullivan, Jacintha ^a   Veale, Douglas J ^a   Fearon, Ursula ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALPHA SMOOTH MUSCLE ACTIN; BLOOD CLOTTING FACTOR 8; NERVE CELL ADHESION MOLECULE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; OSTEOARTHRITIS; OXIDATIVE STRESS; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIUM; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS; BLOOD VESSELS; CELL HYPOXIA; DNA DAMAGE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NEURAL CELL ADHESION MOLECULES; OXYGEN; SYNOVIAL MEMBRANE;

EID: 77649132515     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27287     Document Type: Article

References (50)

1. Koch AE. Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 2003;62 Suppl 2:ii60-67.
2. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
3. Reece RJ, Canete JD, Parsons WJ, Emery P, Veale DJ. Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum 1999;42:1481-4.
4. Fearon U, Giosios K, Fraser A, Reece R, Emery P, Jones PF, et al. Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 2003;30:260-8.
5. Van Kuijk AW, Reinders-Blankert P, Smeets TJ, Dijkmans BA, Tak PP. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann Rheum Dis 2006;65:1551-7.
6. Darland DC, D'Amore PA. TGF is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells. Angiogenesis 2001;4:11-20.
7. Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A 2002;99:11205-10.
8. Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 1998;83:233-40.
9. Zhang J, Cao R, Zhang Y, Jia T, Cao Y, Wahlberg E. Differential roles of PDGFR-α and PDGFR-α in angiogenesis and vessel stability. FASEB J 2008;23:153-63.
10. Schomber T, Kopfstein L, Djonov V, Albrecht I, Baeriswyl V, Strittmatter K, et al. Placental growth factor 1 attenuates vascular endothelial growth factor-A dependent tumor angiogenesis during β cell carcinogenesis. Cancer Res 2007;67:10840-8.
11. Gerhardt H, Semb H. Pericytes: gatekeepers in tumour cell metastasis? J Mol Med 2008;86:135-144.
12. Hellstrom M, Gerhardt H, Kalen M, Li X, Eriksson U, Wolburg H, et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 2001;153:543-54.
13. Perl A-K, Dahl U, Wilgenbus P, Cremer H, Semb H, Christofori G. Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic β tumor cells. Nat Med 1999;5:286-91.
14. Xian X, Hakansson J, Stahlberg A, Lindblom P, Betsholtz C, Gerhardt H, et al. Pericytes limit tumor cell metastasis. J Clin Invest 2006;116:642-51.
15. Saretzki G, Zglinicki T. Replicative aging, telomeres, and oxidative stress. Ann NY Acad Sci 2002;959:24-29.
16. Hitchon CA, El-Gabalawy HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004;6:265-78.
17. Lund-Olesen K. Oxygen tension in synovial fluids. Arthritis Rheum 1970;13:769-76.
18. Sivakumar B, Akhavani MA, Winlove CP, Taylor PC, Paleolog EM, Kang N. Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis. J Hand Surg Am 2008;33:49-58.
19. Hollander AP, Corke KP, Freemont AJ, Lewis CE. Expression of hypoxia-inducible factor 1α by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum 2001;44:1540-4.
20. Hitchon C, Wong K, Ma G, Reed J, Lyttle D, El-Gabalawy H. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum 2002;46:2587-97.
21. Diez H, Fischer A, Winkler A, Hu C-J, Hatzopoulos AK, Breier G, et al. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Exp Cell Res 2007;313:1-9.
22. Seven A, Guzel S, Aslan M, Hamuryudan V. Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. Clin Biochem 2008;41:538-43.
23. Chow E, Thirlwell C, Macrae F, Lipton L. Colorectal cancer and inherited mutations in base-excision repair. Lancet Oncol 2004;5: 600-6.
24. Sheridan J, Wang L-M, Tosetto M, Sheahan K, Hyland J, Fennelly D, et al. Nuclear oxidative damage correlates with poor survival in colorectal cancer. Br J Cancer 2008;100:381-8.
25. Minuz P, Fava C, Cominacini L. Oxidative stress, antioxidants, and vascular damage. Br J Clin Pharmacol 2006;61:774-7.
26. Maurice M, Nakamura H, van der Voort E, van Vliet A, Staal F, Tak P, et al. Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. J Immunol 1997;158:1458-65.
27. Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci U S A 1997;94: 10895-900.
28. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
29. Veale D, Rogers S, FitzGerald O. Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 1994;33:133-8.
30. Betsholtz C, Lindblom P, Gerhardt H. Role of pericytes in vascular morphogenesis. In: Clauss M, Breier G, editors. Mechanisms of angiogenesis; Basel: Birkhauser; 2005. p. 115-25.
31. Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 2003;314:15-23.
32. Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 2005;7:452-64.
33. Benjamin L, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998;125:1591-8.
34. Chan-Ling T, Page MP, Gardiner T, Baxter L, Rosinova E, Hughes S. Desmin ensheathment ratio as an indicator of vessel stability: evidence in normal development and in retinopathy of prematurity. Am J Pathol 2004;165:1301-13.
35. Allt G, Lawrenson JG. Pericytes: cell biology and pathology. Cells Tissues Organs 2001;169:1-11.
36. Hakansson J, Xian X, He L, Stahlberg A, Nelander S, Samuelsson T, et al. Neural cell adhesion molecule-deficient β-cell tumorigenesis results in diminished extracellular matrix molecule expression and tumour cell-matrix adhesion. Tumour Biol 2005;26: 103-12.
37. Von der Ohe M, Wheeler SF, Wuhrer M, Harvey DJ, Liedtke S, Muhlenhoff M, et al. Localization and characterization of polysialic acid-containing N-linked glycans from bovine NCAM. Glycobiology 2002:12:47-63.
38. Khong T, Larsen H, Raatz Y, Paleolog E. Angiogenesis as a therapeutic target in arthritis: learning the lessons of the colorectal cancer experience. Angiogenesis 2007;10:243-58.
39. Walsh DA, Wade M, Mapp PI, Blake DR. Focally regulated endothelial proliferation and cell death in human synovium. Am J Pathol 1998;152:691-702.
40. Mansson B, Carey D, Alini M, Ionescu M, Rosenberg LC, Poole A R, et al. Cartilage and bone metabolism in rheumatoid arthritis: differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest 1995;95:1071-7.
41. Hirohata S, Sakakibara J. Angioneogenesis as a possible elusive triggering factor in rheumatoid arthritis. Lancet 1999;353:1331.
42. Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D, et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, doubleblind, parallel treatment trial. Lancet 2008;372:375-82.
43. Stevens CR, Blake DR, Merry P, Revell PA, Levick JR. A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum 1991;34: 1508-13.
44. Gackowski D, Banaszkiewicz Z, Rozalski R, Jawien A, Olinski R. Persistent oxidative stress in colorectal carcinoma patients. Int J Cancer 2002;101:395-7.
45. De Leo ME, Tranghese A, Passantino M, Mordente A, Lizzio MM, Galeotti T, et al. Manganese superoxide dismutase, glutathione peroxidase, and total radical trapping antioxidant capacity in active rheumatoid arthritis. J Rheumatol 2002;29:2245-6.
46. Marklund SL, Bjelle A, Elmqvist LG. Superoxide dismutase isoenzymes of the synovial fluid in rheumatoid arthritis and in reactive arthritides. Ann Rheum Dis 1986;45:847-51.
47. Maurice MM, Nakamura H, Gringhuis S, Okamoto T, Yoshida S, Kullmann F, et al. Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 1999;42:2430-9.
48. Henrotin YE, Bruckner P, Pujol J-PL. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 2003;11:747-55.
49. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M, et al. Novel role of gp91phox-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 2002;91:1160-7.
50. Thomas SN, Soreghan BA, Nistor M, Sarsoza F, Head E, Yang AJ. Reduced neuronal expression of synaptic transmission modulator HNK-1/neural cell adhesion molecule as a potential consequence of amyloid β-mediated oxidative stress: a proteomic approach. J Neurochem 2005;92:705-17.